webinar register page

Webinar banner
Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these high- cost, high-touch treatments?
Category: BioTech
> Rare Genetic Disorders

> Tanya Lewis
Associate Editor for Health and Medicine, Scientific American

> Pushkal Garg, MD
Chief Medical Officer, Alnylam
> Jonathan Sorof, MD
Senior Vice President, Head of Medical Affairs, Global Blood TherapeuticsTherapeutics
> David J. Lennon (Dave)
President, Novartis Gene Therapies

Oct 27, 2020 01:30 PM in Eastern Time (US and Canada)

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.